The Medicine Maker / Power List / 2016

The Power List 2016

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within our field?

Power List

Heather Bresch

Chief Executive Officer and Executive Director, Mylan

Catherine Tuleu

Reader, University College London School of Pharmacy

Harold Varmus

Lewis Thomas University Professor, Weill Cornell Medical College

Raman Singh

President, Mundipharma Asia Pacific, Latin America, Middle East and Africa

David Baltimore

President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology

Anthony Fauci

Director, US National Institute of Allergy and Infectious Diseases (NIAID)

Thomas Cech

Distinguished Professor, University of Colorado Boulder

Carol Lynch

Global Head of Biopharmaceuticals, Sandoz

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Kiran Mazumdar-Shaw

Chairperson and Managing Director of Biocon

Peter Seeberger

Director at the Max-Planck Institute for Colloids and Interfaces, and Professor, Free University of Berlin

Shinya Yamanaka

Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University

Martin VanTrieste

Senior Vice President of Quality, Amgen

Gert Riethmueller

Professor Emeritus of Immunology, Ludwig-Maximillian University of Munich

J. Craig Venter

Founder, Chairman and Chief Executive Officer of the J. Craig Venter Institute

Keith Thompson

Chief Executive, Cell and Gene Therapy Catapult

John Talley

Chief Scientific Officer, Euclises Pharmaceuticals

Bill Lundberg

Chief Scientific Officer, CRISPR Therapeutics

Rino Rappuoli

Chief Scientist and Head of External R&D, GSK Vaccines

Ibraheem “Ibs” Mahmood

President and Chief Executive Officer, DrugDev

James Agalloco

President, Agalloco & Associates

María José Alonso

Professor of Biopharmaceutics and Pharmaceutical Technology, University of Santiago de Compostela

Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics

Phil S. Baran

Darlene Shiley Professor, The Scripps Research Institute

Mary C. Beckerle

Chief Executive Officer and Director of Huntsman Cancer Institute, University of Utah

David Bentley

Vice President and Chief Scientist, Illumina

Jonathan Bones

Principal Investigator, NIBRT Characterization and Comparability Laboratory, NIBRT – The National Institute for Bioprocessing Research and Training

Olivier Brandicourt

Chief Executive Officer, Sanofi

Carsten Brockmeyer

Chief Executive Officer, Formycon

Pierre Chambon

Chair of Molecular Genetics and Biology, University of Strasbourg Institute for Advanced Study

John Chiminski

President and Chief Executive Officer, Catalent

William Chin

Chief Medical Officer and Executive Vice President, Scientific and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)

Jean-Paul Clozel

Founder and Chief Executive Officer, Actelion

Stephen T. Colgan

Senior Director, Global CMC, Pfizer Worldwide Research and Development

Meindert Danhof

Professor of Pharmacology, Leiden University

Francis S. Collins

Director, US National Institutes of Health

Mark Davison

Founder, and Chief Executive Officer, Blue Sphere Health

Wendel Doubleday

Director, Process Research & Development, Seattle Genetics

Sir Andrew Dillon

Chief Executive, UK National Institute for Health and Care Excellence (NICE)

Suzanne Farid

Professor of Bioprocess Systems Engineering, University College London

Frances D. Fergusson

President Emeritus, Vassar College

Miguel Forte

Chief Operating Officer, TxCell

Belén Garijo

Chief Executive Officer, Healthcare, Merck Group

Kenneth Getz

Director, Sponsored Research Programs and Associate Professor, CSDD, Tufts University School of Medicine; Founder and Board Chair, CISCRP

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma

Laurent Grandidier

Chief Executive Officer, Xeltis

Fiona Greer

Global Director, BioPharma Services Development – Life Sciences, SGS

Jane Griffiths

Company Group Chairman, Janssen, Europe, Middle East & Africa (EMEA)

Helen Hobbs

Professor, Internal Medicine and Molecular Genetics; Director, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center

SeungSuh (Stanley) Hong

President and Chief Executive Officer, Celltrion Healthcare Co. Ltd

Robert J. Hugin

Executive Chairman, Celgene

Mir Imran

Chairman & Chief Executive Officer, InCube Labs

Jayasree K. Iyer

Executive Director, Access to Medicine Foundation

Bahija Jallal

Executive Vice President, AstraZeneca, and Head of MedImmune

Carl June

Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

Michael Kopcha

Director, Office of Pharmaceutical Quality (OPQ), FDA

Siu Ping Lam

Director, Licensing Division, UK Medicines and Healthcare products Regulatory Agency

Robert Langer

David H. Koch Institute Professor, Massachusetts Institute of Technology

John C. Lechleiter

Chairman, President and Chief Executive Officer, Eli Lilly and Company

Andrew Lees

Scientific Director, Fina BioSolutions LLC

Claus-Michael Lehr

Professor, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research (HZI); Saarland University

Arthur D. Levinson

Chief Executive Officer, Calico

Olivier Loeillot

General Manager of Genomics & Cellular Research, GE Healthcare’s Life Sciences business

Archie Lovatt

Ruth McKernan

Chief Executive, Innovate UK

Christian Luber

Line Manager, Protein Characterization, Protein Engineering Novo Nordisk A/S

Richard A. Miller

Co-Founder President and Chief Executive Officer, Corvus Pharmaceuticals

Randy Mrsny

Professor, Department of Pharmacy and Pharmacology, University of Bath

Ian Muir

Managing Director, Aesica

Kary Mullis

Chief Scientific Advisor, Altermune Technologies

Niclas Nilsson

Head of R&D Open Innovation, LEO Pharma

Daniel O’Connor

Expert Medical Assessor, UK Medicines and Healthcare products Regulatory Agency

Brian Overstreet

Co-Founder and President, Advera Health Analytics

Elizabeth Parrish

Chief Executive Officer, BioViva Sciences

Nicholas A. Peppas

Professor of Chemical Engineering, University of Texas at Austin

Daniel Podolsky

President, University of Texas Southwestern Medical Center

Chris Porter

Professor, Monash Institute of Pharmaceutical Sciences

G. V. Prasad

Chief Executive Officer, Dr. Reddy’s Laboratories

Guido Rasi

Executive Director, European Medicines Agency

Clive Roberts

Professor, School of Pharmacy, University of Nottingham

Ian C. Read

Chairman of the Board and Chief Executive Officer, Pfizer

Robin Robinson

Retired

Tomasz Sablinski

Co-Founder and Chief Executive Officer,Transparency Life Sciences

Charles L. Sawyers

Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center

Andreas Seidel-Morgenstern

Director, Department of Physical and Chemical Foundation of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems

George Scangos

Chief Executive Officer, Biogen Idec

Dolores Schendel

Chief Executive Officer, Medigene AG

Joseph Schlessinger

William H. Prusoff Professor and Chairman of the Pharmacology Department, Yale School of Medicine; Director, Yale Cancer Biology Institute

Severin Schwan

Chief Executive Officer, Roche Group

Andy Skibo

Head of Global Biologics Operations and Global Engineering at AstraZeneca/MedImmune

Moncef Slaoui

Chairman of Vaccines, GlaxoSmithKline

Manish Soman

President and Chief Executive Officer, Sciformix

Lars Rebien Sørensen

President and Chief Executive Officer, Novo Nordisk A/S

Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

Abbe Steel

Founder and Chief Executive Officer, HealthiVibe

Nigel Theobald

Founder and Chief Executive Officer, N4 Pharma

Martin Tolar

Founder, President and Chief Executive Officer, Alzheon

Bernhardt Trout

Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, Massachusetts Institute of Technology

Timothy Wright

Executive Vice President, Translational Sciences, Calibr

Vikramaditya G. Yadav

Assistant Professor, Department of Chemical and Biological Engineering, The University of British Columbia

False

Explore

Featured Topics

Issues

Techniques & Tools

Applications & Fields

News & Blogs

Community & Awards